What skin peptide research explores
Peptides are short chains of amino acids. Some are studied as signals in skin and hair biology; others are designed as ingredients in topical cosmetic formulas. Their effect cannot be assumed from the name alone: the exact sequence, finished formula, skin delivery and outcome measured all matter.
Peptides appearing in beauty research
These examples are research topics, not evidence that a vial, injection or any specific product improves appearance. Findings from one route or formulation do not automatically apply to another.
GHK-Cu: A copper-binding tripeptide studied in skin-cell and tissue research. Published reviews describe substantial preclinical interest, but limited and varied human evidence; small topical studies do not establish the performance or safety of other formulations.
AHK-Cu: A related copper-binding peptide. A frequently cited dermatology study examined cultured dermal papilla cells and human hair follicles outside the body. That is early laboratory evidence, not a clinical demonstration of a cosmetic benefit in people.
SNAP-8 (acetyl hexapeptide-8): Studied as a topical cosmetic-formulation ingredient. One short controlled study tested it in a hyaluronic-acid microneedle patch alongside other components, so the result cannot be attributed to SNAP-8 alone or generalised to a different product.
GHK-Cu · AHK-Cu · SNAP-8
A cosmetic peptide in a finished topical formula is not interchangeable with a concentrated powder, injectable vial or product delivered by microneedling. Evidence and safety must be assessed for the specific product and use.
This page is educational and does not recommend using peptide products. In Australia, a peptide product’s regulatory status depends on its ingredients, intended use and presentation. The TGA says therapeutic peptide products generally need to be included in the ARTG before supply or advertising, unless a specific exception applies; “research use only” wording does not remove those obligations. Read the TGA guidance.